<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Clements DR</submitter><funding>Nova Scotia Health Research Foundation</funding><funding>Terry Fox Research Institute</funding><funding>NIDDK NIH HHS</funding><funding>National Institute of Diabetes and Digestive and Kidney Diseases</funding><funding>Beatrice Hunter Cancer Research Institute</funding><funding>Wellcome Trust</funding><funding>Canadian Institutes of Health Research</funding><funding>Canadian Cancer Society Research Institute</funding><pagination>3391-3406</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5648240</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>16(9)</volume><pubmed_abstract>Myeloid cells play a central role in the context of viral eradication, yet precisely how these cells differentiate throughout the course of acute infections is poorly understood. In this study, we have developed a novel quantitative temporal in vivo proteomics (QTiPs) platform to capture proteomic signatures of temporally transitioning virus-driven myeloid cells directly in situ, thus taking into consideration host-virus interactions throughout the course of an infection. QTiPs, in combination with phenotypic, functional, and metabolic analyses, elucidated a pivotal role for inflammatory CD11b&lt;sup>+&lt;/sup>, Ly6G&lt;sup>-&lt;/sup>, Ly6C&lt;sup>high-low&lt;/sup> cells in antiviral immune response and viral clearance. Most importantly, the time-resolved QTiPs data set showed the transition of CD11b&lt;sup>+&lt;</pubmed_abstract><journal>Journal of proteome research</journal><pubmed_title>Quantitative Temporal in Vivo Proteomics Deciphers the Transition of Virus-Driven Myeloid Cells into M2 Macrophages.</pubmed_title><pmcid>PMC5648240</pmcid><funding_grant_id>108070/Z/15/Z</funding_grant_id><funding_grant_id>K01 DK098285</funding_grant_id><pubmed_authors>Holay N</pubmed_authors><pubmed_authors>Gujar S</pubmed_authors><pubmed_authors>Kennedy BE</pubmed_authors><pubmed_authors>Sterea A</pubmed_authors><pubmed_authors>Weekes MP</pubmed_authors><pubmed_authors>Clements DR</pubmed_authors><pubmed_authors>Konda P</pubmed_authors><pubmed_authors>Sharif T</pubmed_authors><pubmed_authors>Almasi S</pubmed_authors><pubmed_authors>Lee PW</pubmed_authors><pubmed_authors>Helson E</pubmed_authors><pubmed_authors>Paulo JA</pubmed_authors><pubmed_authors>Gygi SP</pubmed_authors><pubmed_authors>Murphy JP</pubmed_authors><pubmed_authors>Kim Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Quantitative Temporal in Vivo Proteomics Deciphers the Transition of Virus-Driven Myeloid Cells into M2 Macrophages.</name><description>Myeloid cells play a central role in the context of viral eradication, yet precisely how these cells differentiate throughout the course of acute infections is poorly understood. In this study, we have developed a novel quantitative temporal in vivo proteomics (QTiPs) platform to capture proteomic signatures of temporally transitioning virus-driven myeloid cells directly in situ, thus taking into consideration host-virus interactions throughout the course of an infection. QTiPs, in combination with phenotypic, functional, and metabolic analyses, elucidated a pivotal role for inflammatory CD11b&lt;sup>+&lt;/sup>, Ly6G&lt;sup>-&lt;/sup>, Ly6C&lt;sup>high-low&lt;/sup> cells in antiviral immune response and viral clearance. Most importantly, the time-resolved QTiPs data set showed the transition of CD11b&lt;sup>+&lt;</description><dates><release>2017-01-01T00:00:00Z</release><publication>2017 Sep</publication><modification>2026-05-04T23:13:44.69Z</modification><creation>2026-04-07T21:03:20.213Z</creation></dates><accession>S-EPMC5648240</accession><cross_references><pubmed>28768414</pubmed><doi>10.1021/acs.jproteome.7b00425</doi></cross_references></HashMap>